isoxazoles has been researched along with paroxetine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saria, A; Schatz, DS | 1 |
| Ancione, M; Avenoso, A; Facciolà, G; Madia, A; Scordo, MG; Spina, E | 1 |
| Furukori, H; Kaneko, S; Nakagami, T; Saito, M; Yasui-Furukori, N | 1 |
| Berwaerts, J; Chang, I; Cleton, A; Eerdekens, M; Herben, V; van de Vliet, I; van Hoek, P | 1 |
| Canovi, M; Dallanoce, C; De Amici, M; De Micheli, C; Gobbi, M; Matera, C; Mennini, T | 1 |
| Hochfeld, M; Meng, X; Potkin, SG; Preskorn, S | 1 |
| Preskorn, SH | 1 |
3 trial(s) available for isoxazoles and paroxetine
| Article | Year |
|---|---|
Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Schizophrenia | 2005 |
The effects of paroxetine on the pharmacokinetics of paliperidone extended-release tablets.
Topics: Adolescent; Adult; Antipsychotic Agents; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Paroxetine; Pyrimidines; Young Adult | 2009 |
A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dibenzothiazepines; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Electrocardiography; Enzyme Inhibitors; Female; Genotype; Heart Rate; Humans; Isoxazoles; Ketoconazole; Linear Models; Long QT Syndrome; Male; Middle Aged; Paroxetine; Pharmacogenetics; Phenotype; Piperazines; Piperidines; Quetiapine Fumarate; Thiazoles; United States; Young Adult | 2013 |
4 other study(ies) available for isoxazoles and paroxetine
| Article | Year |
|---|---|
Simultaneous determination of paroxetine, risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with coulometric detection.
Topics: Chromatography, High Pressure Liquid; Colorimetry; Drug Monitoring; Humans; Isoxazoles; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Spectrophotometry, Ultraviolet | 2000 |
Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine.
Topics: Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Selective Serotonin Reuptake Inhibitors | 2001 |
A novel spirocyclic tropanyl-Δ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake.
Topics: Animals; Binding Sites; Cerebral Cortex; Citalopram; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Isoxazoles; Molecular Structure; Paroxetine; Rats; Serotonin; Serotonin Plasma Membrane Transport Proteins; Spiro Compounds; Structure-Activity Relationship; Synaptosomes | 2012 |
Complexities of personalized medicine: how genes, drug-drug interactions, dosing schedules, and other factors can combine to produce clinically meaningful differences in a drug's effect.
Topics: Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Depressive Disorder, Major; Dizziness; Drug Interactions; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Isoxazoles; Male; Paroxetine; Pharmacogenetics; Piperidines; Precision Medicine | 2013 |